06 December 2017
Notwithstanding the market economy, the state must constantly monitor the prices of medicines, because this issue concerns everyone who lives in Russia. This statement was made by Prime Minister Dmitry Medvedev in his interview with Russian TV channels.
“It is the area that requires a sustained control from the state, which should be always stringent. Whose duty is it? This is the duty of the Federal Antimonopoly Service as a part of general state regulation,” said the head of the government.
According to the Prime Minister, the funds allocated annually for procurement of vital and essential drugs (VED) amount to 0.5 trillion rubles. He reminded that, today, the list approved by the government has grown to as many as 699 items.
The Prime Minister added that, in monetary terms, 70% of drugs are purchased outside Russia and only 30% in the country. As for the breakdown by individual brand items, Mr. Medvedev said that 60% of items are purchased in Russia and only 40% abroad. But, when it comes to VED, 85% of medicines are bought in Russia.
According to the Prime Minister, this does not only provide support to the Russian pharmaceutical industry but, objectively, is less expensive and does not depend on currency fluctuations.
“This is exactly the import substitution that we are working on and to which we must pay very close attention,” he said.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024